descriptionPublicationkeyboard_double_arrow_right Article 01 May 1991 English Publisher:SAGE PublicationsJournal:Angiology, volume 42, pages 387-396 (issn: 0003-3197, eissn: 1940-1574,

Authors: Allen J. Sedman; Edward L. Posvar;

doi: 10.1177/000331979104200506

pmid: 2035890

ACE Inhibitors in the Elderly

- Summary
- Subjects
- Metrics

Abstract

As the population with hypertension becomes older, it is important to determine the properties of angiotensin-converting enzyme (ACE) inhibitors in the elderly. The pharmacokinetics and efficacy of captopril, enalapril, and a new once-daily ACE inhibitor, quinapril for the treatment of hypertension in young and elderly patients are reviewed, and the safety profiles of these agents in young and elderly patients are discussed. Although the safely profile of all three drugs is very favorable, quinapril tended to be better tolerated by patients of all ages in comparative clinical trials.

Related Organizations

Parke-Davis
United States

Keywords

Captopril, Enalapril, Tetrahydroisoquinolines, Hypertension, Quinapril, Humans, Angiotensin-Converting Enzyme Inhibitors, Isoquinolines, Aged

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%